Adia Nutrition (ADIA) Payables (2024 - 2026)
Adia Nutrition's (ADIA) quarterly Payables came in at $27917.0 in Q1 2026, up 1066.61% quarter-over-quarter from $2393.0 in Q4 2025.
Analysis
Adia Nutrition (ADIA) Payables (2024 - 2026) Analysis & Trends
Adia Nutrition (ADIA) has reported Payables for 3 consecutive years, with $27917.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Payables changed N/A year-over-year to $27917.0 in Q1 2026; TTM through Mar 2026 was $27917.0, a N/A change from a year earlier, with the FY2025 full-year figure at $2393.0, down 50.92% from the prior year.
- Payables was $27917.0 for Q1 2026 at Adia Nutrition, up from $2393.0 in the prior quarter.
- Over five years, Payables peaked at $27917.0 in Q1 2026 and troughed at $2393.0 in Q4 2025.
- A 3-year average of $11728.7 and a median of $4876.0 in 2024 frame the typical range for Payables.
- The widest YoY moves for Payables: up 50.92% in 2025, down 50.92% in 2025.
- Over 3 years, Payables stood at $4876.0 in 2024, then tumbled by 50.92% to $2393.0 in 2025, then soared by 1066.61% to $27917.0 in 2026.
- The last three Payables figures came in at $27917.0 (Q1 2026), $2393.0 (Q4 2025), and $4876.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 9.96 Bn | 9.12 Bn | 112.79 Mn | 6.54 Mn |
| 2 | CRISPR Therapeutics AG | 5.47 Bn | 5.47 Bn | - | 11.31 Mn |
| 3 | Iovance Biotherapeutics | 4.64 Bn | 4.35 Bn | 55.72 Mn | 26.21 Mn |
| 4 | Legend Biotech | 3.25 Bn | 2.28 Bn | 251.50 Mn | 77.30 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 4.98 Mn |
| 6 | Precigen | 2.79 Bn | 2.79 Bn | 52.17 Mn | 5.30 Mn |
| 7 | Beam Therapeutics | 2.58 Bn | 2.58 Bn | - | 22.50 Mn |
| 8 | Sarepta Therapeutics | 2.12 Bn | 1.33 Bn | 251.87 Mn | 50.98 Mn |
| 9 | Vericel | 2.05 Bn | 1.89 Bn | 56.40 Mn | 20.61 Mn |
| 10 | Adia Nutrition | 11.33 Mn | 11.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 27,917.00 |
| Dec 31, 2025 | 2,393.00 |
| Dec 31, 2024 | 4,876.00 |